Autopsy report · NCT04638751

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

“Currently no funding to continue study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 8 months before it started.
• Suspended: paused, and may or may not restart.
• 5,000 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

Persephone Biosciences

Sponsor type

Industry

Conditions

Non-small Cell Lung Cancer; Colorectal Cancer; Triple Negative Breast Cancer; Pancreas Cancer

Interventions

Immunotherapy; Chemotherapy; CRC surgical resection; Colonoscopy

Participants

5,000 (planned, not actual)

Sites

10

Countries

United States

Trials that died the same way

• Regulation of the Release of Inflammatory Mediators From Blood Leukocytes
  “No funding for the study” (82% match in meaning)
• ITT-5 Mechanisms of Spermatogenesis in Man
  “No funding was obtained for this study.” (80% match in meaning)
• Muscle, Essential Amino Acids, and eXercise in Heart Failure
  “There is no longer any funding to support the study” (80% match in meaning)
• CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
  “there was no funding to begin the study” (78% match in meaning)
• Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy
  “Funding for study not procured.” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.